RARA CRAFT DATABASE for FDA Medical Devices
PMAP150035

FDA DEVICE FACTS

Aveir VR Leadless System

ABBOTT MEDICAL

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEMarch 31, 2022PRODUCT CODEPNJ

Indications for use

The Aveir™ Leadless Pacemaker is indicated for patients with bradycardia and:

• Normal sinus rhythm with only rare episodes of A-V block or sinus arrest

• Chronic atrial fibrillation

• Severe physical disability Rate-Modulated Pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. MR Conditional Aveir™ Leadless Pacemaker is conditionally safe for use in the MRI environment and according to the instructions in the Abbott MRI-Ready Leadless System Manual. Aveir™ Delivery Catheter: The Aveir Delivery Catheter is intended to be used in the peripheral vasculature and the cardiovascular system to deliver and manipulate an LP. Delivery and manipulation include implanting an LP within the target chamber of the heart.

Aveir™ Link Module: The Aveir Link Module is intended to be used in conjunction with a Merlin™ PCS Programmer to interrogate and program an Aveir LP and to monitor LP function during an implant, retrieval, or follow-up procedure.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026